Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation
CTSC plays a crucial role in driving TME remodeling and the progression of drug resistance in ESCC, making it a potential target for clinical therapy.
Authors
- Yanru Qin (ORCID: https://orcid.org/0000-0001-7576-5129)
- Yongxu Jia
- Wenjia Wang (ORCID: https://orcid.org/0000-0003-0336-9412)
- Jing Li (ORCID: https://orcid.org/0000-0002-1690-9548)
- Jiayao Xu (ORCID: https://orcid.org/0009-0003-8849-9407)
- Xin Sui (ORCID: https://orcid.org/0000-0001-5716-045X)
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1585139
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01